Aralik 2007
Gastrointestinal sistemde argon plazma koagulasyon (APC)uygulamasi: Klinik deneyimlerimiz
Argon plasma coogulation at gastrointestinal system: Clinical experience
- Ana Sayfa
- Sayılar
- Aralik 2007
- Gastrointestinal sistemde argon plazma koagulasyon (APC)uygulamasi: Klinik deneyimlerimiz...
Özet
Giris ve Amaç: Bu çalismanin amaci, degisik nedenlerle gastrointestinal sistemde argon plazma koagülasyon uygulanilmis olgulari retrospektif olarak degerlendirmektir. Gereç ve Yöntem: Mayis 2005 ile Kasim 2006 arasi Ankara Üniversitesi Tip Fakültesi Gastroenteroloji Bilim Dali endoskopi ünitesinde üst ve alt gastrointesinal sistemde degisik nedenlerle argon plazma koagülasyon uygulanan 92 hastanin (VIO 300 D with argon plazma koagülasyon 2; Erbe Elektromedizin, Tubingen, Germany; pulsed argon plasma coagulation, 20?120 W) verileri degerlendirildi. Bulgular: Argon plazma koagülasyon uygulanan 92 olgunun ortalama yasi 61.94 (3-91 yas arasi) idi. 50 olgu erkek (%54.3), 42 olgu (%45.7) kadindi. 92 olguya toplam 155 seans (ortalama 1.68 seans) argon plazma koagülasyon uygulanildi. Argon plazma koagülasyon endikasyonlari: vasküler lezyonlar 24 olgu, kanayan veya kanama riski olan ülserler 19 olgu, polipektomi sonrasi rezidü önlemek için polip çevresine 17 olgu, gastrointestinal sistem malignitelerinin palyatif tedavisinde, polipektomi veya biopsi sonrasi kanamalarin tedavisi için 11 olgu, inlet patch ablasyonu 11 olgu, Barrett özefagus ablasyonu 5 olgu, radyasyon rektiti 4 olgu, metalik stent kesimi için 1 olgu. Girisimler sirasinda major komplikasyon gözlemez iken sadece 5 olguda minor komplikasyon gözlendi (2 kanama, 1 gögüs agrisi, 2 anorektal agri). Sonuç: Argon plazma koagulasyon uygulamasi farkli gastrointestinal patolojilerinin tedavisinde kullani labilecek güvenli bir yöntemdir.
Abstract
Background and Aims: The aim of this study was to retrospectively analyze use of argon plasma coagulation in lesions of the gastrointestinal tract. Materials and Methods: Data of 92 patients treated with an argon plasma coagulation system in the upper and lower gastrointestinal tract between May 2005 and November 2006, using a VIO argon plasma coagulation device (VIO 300 D with argon plasma coagulation 2; Erbe Elektromedizin, Tubingen, Germany; pulsed argon plasma coagulation, 20?120 W), were reviewed and analyzed. Results: Ninety-two patients were treated with argon plasma coagulation, and the mean age was 61.84 (3-91) years. Fifty of these patients were male (54.3%) and 42 (45.7%) were female. Ninety-two patients were treated in 155 sessions. The mean number of treatment sessions required was 1.68 (1?12). Indications were vascular lesions (24 patients), bleeding peptic ulcers or prevention of bleeding recurrence (19 patients), adjunctive therapy after piecemeal resection of colonic polyps (17 patients), palliative treatment of gastrointestinal tract cancers, treatment of bleeding after polypectomy or biopsy (11 patients), ablation of inlet patch (11 patients), ablation of Barrett?s esophagus (5 patients), radiation proctopathy (4 patients), and metallic stent cut (1 patient). There were no major complications observed. Minor complications were seen in only five patients (bleeding in 2, chest pain in 1, anal pain in 2 patients). Conclusions: Argon plasma coagulation system was an effective and safe method in various gastrointestinal pathologies.
